BRPI0418219A - sìntese de (r)-5-(2-aminopropil)-2-metoxibenzenossulfonamida opticamente pura - Google Patents

sìntese de (r)-5-(2-aminopropil)-2-metoxibenzenossulfonamida opticamente pura

Info

Publication number
BRPI0418219A
BRPI0418219A BRPI0418219-7A BRPI0418219A BRPI0418219A BR PI0418219 A BRPI0418219 A BR PI0418219A BR PI0418219 A BRPI0418219 A BR PI0418219A BR PI0418219 A BRPI0418219 A BR PI0418219A
Authority
BR
Brazil
Prior art keywords
aminopropyl
synthesis
optically pure
methoxybenzenesulfonamide
methoxybenzenesulphonamide
Prior art date
Application number
BRPI0418219-7A
Other languages
English (en)
Inventor
Barbara Mohar
Original Assignee
Lek Pharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lek Pharmaceuticals filed Critical Lek Pharmaceuticals
Publication of BRPI0418219A publication Critical patent/BRPI0418219A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/36—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/02—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of sulfonic acids or halides thereof
    • C07C303/04—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of sulfonic acids or halides thereof by substitution of hydrogen atoms by sulfo or halosulfonyl groups
    • C07C303/08—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of sulfonic acids or halides thereof by substitution of hydrogen atoms by sulfo or halosulfonyl groups by reaction with halogenosulfonic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/36—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids
    • C07C303/38—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids by reaction of ammonia or amines with sulfonic acids, or with esters, anhydrides, or halides thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/36—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids
    • C07C303/40—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids by reactions not involving the formation of sulfonamide groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/37—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/45—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups at least one of the singly-bound nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylaminosulfonamides
    • C07C311/46—Y being a hydrogen or a carbon atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

"SìNTESE DE (R)-5-(2-AMINOPROPIL)-2-METOXIBENZENOSSULFONAMIDA OPTICAMENTE PURA". A presente invenção refere-se a um novo processo para a preparação de (R)-5-(2-aminopropil)-2-metoxibenzenossulfonamida opticamente pura, que é um intermediário na síntese de tamsulosina.
BRPI0418219-7A 2003-12-29 2004-12-27 sìntese de (r)-5-(2-aminopropil)-2-metoxibenzenossulfonamida opticamente pura BRPI0418219A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SI200300320A SI21655A (sl) 2003-12-29 2003-12-29 Sinteza optično čistega (R)-5-(2-aminopropil)-2-metoksibenzensulfonamida
PCT/SI2004/000046 WO2005063701A1 (en) 2003-12-29 2004-12-27 Synthesis of optically pure (r)-5-(2-aminopropyl)-2-methoxybenzenesulphonamide

Publications (1)

Publication Number Publication Date
BRPI0418219A true BRPI0418219A (pt) 2007-04-27

Family

ID=34738130

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0418219-7A BRPI0418219A (pt) 2003-12-29 2004-12-27 sìntese de (r)-5-(2-aminopropil)-2-metoxibenzenossulfonamida opticamente pura

Country Status (13)

Country Link
US (1) US7538246B2 (pt)
EP (1) EP1704140B1 (pt)
JP (1) JP4695095B2 (pt)
CN (1) CN1902165B (pt)
AT (1) ATE502007T1 (pt)
AU (1) AU2004309314B2 (pt)
BR (1) BRPI0418219A (pt)
CA (1) CA2549604C (pt)
DE (1) DE602004031879D1 (pt)
RU (1) RU2419605C2 (pt)
SI (2) SI21655A (pt)
WO (1) WO2005063701A1 (pt)
ZA (1) ZA200604812B (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101284807B (zh) * 2008-06-11 2010-12-08 药源药物化学（上海）有限公司 盐酸坦索罗辛的制备方法
CN102898336B (zh) * 2012-10-16 2013-11-27 北京悦康科创医药科技有限公司 一种盐酸坦索罗辛的制备方法
MX2017003290A (es) * 2014-09-16 2017-06-21 Shionogi & Co Proceso para la preparacion de derivados de trifenilbuteno.
EA039048B1 (ru) 2016-03-15 2021-11-26 Сионоги Энд Ко., Лтд. Способ получения производных феноксиэтанола
CN110156643A (zh) * 2019-06-24 2019-08-23 新乡市锦源化工有限公司 一种对乙酰氨基苯磺酰氯高效催化制备方法
CN113582947B (zh) * 2021-09-07 2023-06-20 南开大学 一种脱除胺的磺酰基保护的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3860647A (en) * 1973-08-20 1975-01-14 Smithkline Corp {60 -Aminomethyl-4-hydroxy-3-sulfamyl-benzyl alcohols and 4-hydroxy-3-sulfamyl phenethylamines
US5391825A (en) * 1980-02-08 1995-02-21 Yamanouchi Pharmaceutical Co., Ltd. Sulfamoyl substituted phenethylamine intermediates
JPS56110665A (en) * 1980-02-08 1981-09-01 Yamanouchi Pharmaceut Co Ltd Sulfamoyl-substituted phenetylamine derivative and its preparation
JPS62114952A (ja) * 1985-11-13 1987-05-26 Yamanouchi Pharmaceut Co Ltd 置換フエネチルアミン誘導体の製造法
JP2696363B2 (ja) * 1988-02-19 1998-01-14 北陸製薬株式会社 フェノキシエチルアミン誘導体
RU2205001C2 (ru) * 2001-06-05 2003-05-27 Новосибирский научно-исследовательский институт туберкулеза Способ определения вида лечения больных с доброкачественной гиперплазией предстательной железы
CZ20013848A3 (cs) 2001-10-25 2003-05-14 Léčiva, A.S. Způsob výroby (R)-(-)-5-[2-[2-(2-ethoxyfenoxy)ethylamino]propyl]-2-methoxybenzensulfonamidu

Also Published As

Publication number Publication date
EP1704140A1 (en) 2006-09-27
AU2004309314B2 (en) 2011-09-01
SI21655A (sl) 2005-06-30
EP1704140B1 (en) 2011-03-16
CN1902165A (zh) 2007-01-24
WO2005063701A1 (en) 2005-07-14
US20070155989A1 (en) 2007-07-05
JP4695095B2 (ja) 2011-06-08
ATE502007T1 (de) 2011-04-15
SI1704140T1 (sl) 2011-10-28
RU2419605C2 (ru) 2011-05-27
AU2004309314A1 (en) 2005-07-14
JP2007517796A (ja) 2007-07-05
CA2549604C (en) 2012-09-18
RU2006127298A (ru) 2008-02-10
US7538246B2 (en) 2009-05-26
DE602004031879D1 (en) 2011-04-28
ZA200604812B (en) 2007-09-26
CN1902165B (zh) 2010-06-16
CA2549604A1 (en) 2005-07-14

Similar Documents

Publication Publication Date Title
EA200501222A1 (ru) Дигидроптеридиноны, способ их получения и их применение в качестве лекарственных средств
TW200504089A (en) One step process for the preparation of anticonvulsant derivatives
EA201070186A1 (ru) Способы и соединения, предназначенные для получения ингибиторов котранспортера натрий-глюкозы 2 типа
UA87153C2 (ru) Энантиомерно чистые аминогетероарильные соединения как ингибиторы протеинкиназы
DK1485360T3 (da) Natriumkanalblokkere
EA200702346A1 (ru) КРИСТАЛЛИЧЕСКАЯ ФОРМА 1-ХЛОР-4-(β-D-ГЛЮКОПИРАНОЗ-1-ИЛ)-2-[4-((S)-ТЕТРАГИДРОФУРАН-3-ИЛОКСИ)БЕНЗИЛ]БЕНЗОЛА, СПОСОБ ЕЁ ПОЛУЧЕНИЯ И ЕЁ ПРИМЕНЕНИЕ ДЛЯ ПРИГОТОВЛЕНИЯ ЛЕКАРСТВЕННЫХ СРЕДСТВ
NO20031970L (no) Sammensetninger av optiske lysgjöringsmidler, deres fremstilling og deres anvendelse
ATE427965T1 (de) Antikírper gegen 25-hydroxyvitamin d
EA200700215A1 (ru) Протеиновые гидролизаты, снижающие давление крови
DE602007004494D1 (de) Herstellung von (2r,3r)-3-(3-methoxyphenyl)-n,n,2- trimethylpentanamin
CL2012000114A1 (es) Proceso para la preparacion de compuestos derivados de 5-amino-benzonorbornadieno donde se hacer reaccionar un compuesto de 5-halo-benzonorbornadieno con una bencilamina en prensecia de un catalizador de paladio.
IS7755A (is) Aðferð við framleiðslu á (S,S)-cis-2-benshýdríl-3-bensýlamínókínuklídín
NI200500164A (es) Nueva difenilazetidinona con caracteristicas fisiologicas mejoradas, correspondiente metodo de produccion, medicamentos que contienen dicho compuesto y su uso.
EA200800701A1 (ru) 4-замещенные пирролидин-2-оны и их применение
EA200801560A1 (ru) Бифенилкарбоксамиды
EA200600485A1 (ru) Способ получения производных 2-оксо-1-пирролидина
DK1536685T4 (da) Fremgangsmåde til fremstilling af pasta-ekstruderede sulfonamidsammensætninger
HRP20080057T3 (en) 9,10-alpha,alpha-oh-taxane analogs and methods for production thereof
NO20040388L (no) Fremgangsmåte for fremstilling av beraprost og salter derav, samt forbindelser som er mellomprodukter i fremgangsmåten
SI1704140T1 (sl) Postopek za pripravo (R)-5-(2-aminopril)-2-metoksibenzensulfonamida
DE602004023105D1 (de) HERSTELLUNG VON 4,5-DIALKYL-3-ACYLPYRROL-2-CARBONS ANSCHLIEßENDE ACYLIERUNG
EA200500202A1 (ru) Новый способ синтеза (7-метокси-3,4-дигидро-1-нафталинил)ацетонитрила и его применение при синтезе агомелатина
MY146610A (en) Process of producing bleach boosters
TW200510287A (en) Modafinil synthesis process
DE602006005240D1 (de) Herstellungsverfahren für aztreonam

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 11A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.